Global Human Growth Hormone Drugs Market Insights, Forecast to 2025

Publisher Name :
Date: 03-Jun-2019
No. of pages: 118
Inquire Before Buying

HGH, produced by the pituitary gland, spurs growth in children and adolescents. It also helps to regulate body composition, body fluids, muscle and bone growth, sugar and fat metabolism, and possibly heart function. Produced synthetically, HGH is the active ingredient in a number of prescription drugs and in other products available widely over the Internet.

Human growth hormone is a peptide hormone, stimulating growth in children and adolescents, and is produced by the pituitary gland. It helps in the growth of bones and muscles by specific cellular differentiation. Apart from stimulating growth, the human growth hormone also regulates carbohydrate metabolism, protein metabolism and fat metabolism. Moreover, the usage of human growth hormone drugs in growth hormone deficient patient has shown significant positive results on the patient's working capacity, mental alertness and memory. The over secretion of growth hormone leads to gigantism and its deficiency causes dwarfism. The human growth hormone drugs are developed and manufactured by recombinant DNA technology. Earlier, these drugs were mostly used as replacement therapy in pediatric and adult patients, having the deficiency of growth hormones. However, the technological advancements and increased research and development in growth hormone drugs, have resulted in the development of anti-aging drugs and performance enhancers.

The global Human Growth Hormone Drugs market is valued at 37000 million US$ in 2018 and will reach 66500 million US$ by the end of 2025, growing at a CAGR of 7.6% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Human Growth Hormone Drugs market based on company, product type, end user and key regions.

This report studies the global market size of Human Growth Hormone Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Human Growth Hormone Drugs in these regions.

This research report categorizes the global Human Growth Hormone Drugs market by top players/brands, region, type and end user. This report also studies the global Human Growth Hormone Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Eli Lilly and Company (US)

- Ferring Holding SA (Switzerland)

- Genentech, Inc. (US)

- GeneScience Pharmaceuticals Co., Ltd. (China)

- Merck KgaA (Germany)

- Novo Nordisk A/S (Denmark)

- Pfizer, Inc. (US)

- Sandoz International GmbH (Germany)

Market size by Product

- Norditropin

- Genotropin

- Humatrope

- Saizen

- Omnitrope

- Somatropin Biopartners

Market size by End User

- Prader-Willi Syndrome

- Turner Syndrome

- Short Stature Homeobox Gene

- Small for Gestational Age

- Chronic Renal Insufficiency

- Short Bowel Syndrome

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Human Growth Hormone Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Human Growth Hormone Drugs market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Human Growth Hormone Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Human Growth Hormone Drugs submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Human Growth Hormone Drugs are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Human Growth Hormone Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Human Growth Hormone Drugs Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Human Growth Hormone Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Human Growth Hormone Drugs Market Size Growth Rate by Product
1.4.2 Norditropin
1.4.3 Genotropin
1.4.4 Humatrope
1.4.5 Saizen
1.4.6 Omnitrope
1.4.7 Somatropin Biopartners
1.5 Market by End User
1.5.1 Global Human Growth Hormone Drugs Market Size Growth Rate by End User
1.5.2 Prader-Willi Syndrome
1.5.3 Turner Syndrome
1.5.4 Short Stature Homeobox Gene
1.5.5 Small for Gestational Age
1.5.6 Chronic Renal Insufficiency
1.5.7 Short Bowel Syndrome
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Human Growth Hormone Drugs Market Size
2.1.1 Global Human Growth Hormone Drugs Revenue 2014-2025
2.1.2 Global Human Growth Hormone Drugs Sales 2014-2025
2.2 Human Growth Hormone Drugs Growth Rate by Regions
2.2.1 Global Human Growth Hormone Drugs Sales by Regions
2.2.2 Global Human Growth Hormone Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Human Growth Hormone Drugs Sales by Manufacturers
3.1.1 Human Growth Hormone Drugs Sales by Manufacturers
3.1.2 Human Growth Hormone Drugs Sales Market Share by Manufacturers
3.1.3 Global Human Growth Hormone Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Human Growth Hormone Drugs Revenue by Manufacturers
3.2.1 Human Growth Hormone Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Human Growth Hormone Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Human Growth Hormone Drugs Price by Manufacturers
3.4 Human Growth Hormone Drugs Manufacturing Base Distribution, Product Types
3.4.1 Human Growth Hormone Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Growth Hormone Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Human Growth Hormone Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Human Growth Hormone Drugs Sales by Product
4.2 Global Human Growth Hormone Drugs Revenue by Product
4.3 Human Growth Hormone Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Human Growth Hormone Drugs Breakdown Data by End User
6 North America
6.1 North America Human Growth Hormone Drugs by Countries
6.1.1 North America Human Growth Hormone Drugs Sales by Countries
6.1.2 North America Human Growth Hormone Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Human Growth Hormone Drugs by Product
6.3 North America Human Growth Hormone Drugs by End User
7 Europe
7.1 Europe Human Growth Hormone Drugs by Countries
7.1.1 Europe Human Growth Hormone Drugs Sales by Countries
7.1.2 Europe Human Growth Hormone Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Growth Hormone Drugs by Product
7.3 Europe Human Growth Hormone Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Human Growth Hormone Drugs by Countries
8.1.1 Asia Pacific Human Growth Hormone Drugs Sales by Countries
8.1.2 Asia Pacific Human Growth Hormone Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Human Growth Hormone Drugs by Product
8.3 Asia Pacific Human Growth Hormone Drugs by End User
9 Central & South America
9.1 Central & South America Human Growth Hormone Drugs by Countries
9.1.1 Central & South America Human Growth Hormone Drugs Sales by Countries
9.1.2 Central & South America Human Growth Hormone Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Human Growth Hormone Drugs by Product
9.3 Central & South America Human Growth Hormone Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Human Growth Hormone Drugs by Countries
10.1.1 Middle East and Africa Human Growth Hormone Drugs Sales by Countries
10.1.2 Middle East and Africa Human Growth Hormone Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Human Growth Hormone Drugs by Product
10.3 Middle East and Africa Human Growth Hormone Drugs by End User
11 Company Profiles
11.1 Eli Lilly and Company (US)
11.1.1 Eli Lilly and Company (US) Company Details
11.1.2 Company Business Overview
11.1.3 Eli Lilly and Company (US) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Eli Lilly and Company (US) Human Growth Hormone Drugs Products Offered
11.1.5 Eli Lilly and Company (US) Recent Development
11.2 Ferring Holding SA (Switzerland)
11.2.1 Ferring Holding SA (Switzerland) Company Details
11.2.2 Company Business Overview
11.2.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Products Offered
11.2.5 Ferring Holding SA (Switzerland) Recent Development
11.3 Genentech, Inc. (US)
11.3.1 Genentech, Inc. (US) Company Details
11.3.2 Company Business Overview
11.3.3 Genentech, Inc. (US) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Genentech, Inc. (US) Human Growth Hormone Drugs Products Offered
11.3.5 Genentech, Inc. (US) Recent Development
11.4 GeneScience Pharmaceuticals Co., Ltd. (China)
11.4.1 GeneScience Pharmaceuticals Co., Ltd. (China) Company Details
11.4.2 Company Business Overview
11.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Products Offered
11.4.5 GeneScience Pharmaceuticals Co., Ltd. (China) Recent Development
11.5 Merck KgaA (Germany)
11.5.1 Merck KgaA (Germany) Company Details
11.5.2 Company Business Overview
11.5.3 Merck KgaA (Germany) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Merck KgaA (Germany) Human Growth Hormone Drugs Products Offered
11.5.5 Merck KgaA (Germany) Recent Development
11.6 Novo Nordisk A/S (Denmark)
11.6.1 Novo Nordisk A/S (Denmark) Company Details
11.6.2 Company Business Overview
11.6.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Products Offered
11.6.5 Novo Nordisk A/S (Denmark) Recent Development
11.7 Pfizer, Inc. (US)
11.7.1 Pfizer, Inc. (US) Company Details
11.7.2 Company Business Overview
11.7.3 Pfizer, Inc. (US) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Pfizer, Inc. (US) Human Growth Hormone Drugs Products Offered
11.7.5 Pfizer, Inc. (US) Recent Development
11.8 Sandoz International GmbH (Germany)
11.8.1 Sandoz International GmbH (Germany) Company Details
11.8.2 Company Business Overview
11.8.3 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Products Offered
11.8.5 Sandoz International GmbH (Germany) Recent Development
12 Future Forecast
12.1 Human Growth Hormone Drugs Market Forecast by Regions
12.1.1 Global Human Growth Hormone Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Human Growth Hormone Drugs Revenue Forecast by Regions 2019-2025
12.2 Human Growth Hormone Drugs Market Forecast by Product
12.2.1 Global Human Growth Hormone Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Human Growth Hormone Drugs Revenue Forecast by Product 2019-2025
12.3 Human Growth Hormone Drugs Market Forecast by End User
12.4 North America Human Growth Hormone Drugs Forecast
12.5 Europe Human Growth Hormone Drugs Forecast
12.6 Asia Pacific Human Growth Hormone Drugs Forecast
12.7 Central & South America Human Growth Hormone Drugs Forecast
12.8 Middle East and Africa Human Growth Hormone Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Growth Hormone Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Human Growth Hormone Drugs Product Picture
Table Human Growth Hormone Drugs Market Segments
Table Key Manufacturers Human Growth Hormone Drugs Covered
Table Global Human Growth Hormone Drugs Market Size Growth Rate by Product 2019-2025 (MT) & (Million US$)
Figure Global Human Growth Hormone Drugs Sales Market Share by Product 2014-2025
Figure Norditropin Product Picture
Table Major Manufacturers of Norditropin
Figure Genotropin Product Picture
Table Major Manufacturers of Genotropin
Figure Humatrope Product Picture
Table Major Manufacturers of Humatrope
Figure Saizen Product Picture
Table Major Manufacturers of Saizen
Figure Omnitrope Product Picture
Table Major Manufacturers of Omnitrope
Figure Somatropin Biopartners Product Picture
Table Major Manufacturers of Somatropin Biopartners
Table Global Human Growth Hormone Drugs Market Size Growth Rate by End User 2019-2025 (MT)
Figure Prader-Willi Syndrome
Figure Turner Syndrome
Figure Short Stature Homeobox Gene
Figure Small for Gestational Age
Figure Chronic Renal Insufficiency
Figure Short Bowel Syndrome
Figure Human Growth Hormone Drugs Report Years Considered
Figure Global Human Growth Hormone Drugs Market Size 2014-2025 (Million US$)
Figure Global Human Growth Hormone Drugs Sales 2014-2025 (MT)
Table Global Human Growth Hormone Drugs Market Size by Regions 2014-2019 (MT) & (Million US$)
Table Global Human Growth Hormone Drugs Sales by Regions 2014-2019 (MT)
Table Global Human Growth Hormone Drugs Sales Market Share by Regions 2014-2019
Figure Global Human Growth Hormone Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Human Growth Hormone Drugs Sales Market Share by Regions
Table Global Human Growth Hormone Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Human Growth Hormone Drugs Revenue Market Share by Regions 2014-2019
Figure Global Human Growth Hormone Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Human Growth Hormone Drugs Revenue Market Share by Regions
Table Global Human Growth Hormone Drugs Sales by Manufacturers (2014-2019) (MT)
Table Global Human Growth Hormone Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Human Growth Hormone Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Human Growth Hormone Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Human Growth Hormone Drugs Revenue Share by Manufacturers (2014-2019)
Figure Human Growth Hormone Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Human Growth Hormone Drugs Price (2014-2019) (USD/Kg)
Table Human Growth Hormone Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Human Growth Hormone Drugs Product Type
Table Date of International Manufacturers Enter into Human Growth Hormone Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Human Growth Hormone Drugs Sales by Product (2014-2019) (MT)
Table Global Human Growth Hormone Drugs Sales Share by Product (2014-2019)
Figure Global Human Growth Hormone Drugs Sales Market Share by Product (2014-2019)
Figure Global Human Growth Hormone Drugs Sales Market Share by Product in 2018
Table Global Human Growth Hormone Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Human Growth Hormone Drugs Revenue Share by Product (2014-2019)
Figure Global Human Growth Hormone Drugs Revenue Market Share by Product (2014-2019)
Figure Global Human Growth Hormone Drugs Revenue Market Share by Product in 2018
Table Human Growth Hormone Drugs Price by Product 2014-2019 (USD/Kg)
Table Global Human Growth Hormone Drugs Sales by End User (2014-2019) (MT)
Table Global Human Growth Hormone Drugs Sales Share by End User (2014-2019)
Figure Global Sales Human Growth Hormone Drugs Market Share by End User (2014-2019)
Figure Global Sales Human Growth Hormone Drugs Market Share by End User in 2018
Figure North America Human Growth Hormone Drugs Sales Growth Rate 2014-2019 (MT)
Figure North America Human Growth Hormone Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Human Growth Hormone Drugs Sales by Countries (2014-2019) (MT)
Table North America Human Growth Hormone Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Human Growth Hormone Drugs Sales Market Share by Countries
Table North America Human Growth Hormone Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Human Growth Hormone Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Human Growth Hormone Drugs Revenue Market Share by Countries
Figure United States Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure United States Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (MT)
Figure Canada Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure Canada Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure Mexico Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Human Growth Hormone Drugs Sales by Product (2014-2019) (MT)
Table North America Human Growth Hormone Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Human Growth Hormone Drugs Market Share by Product
Table North America Human Growth Hormone Drugs Sales by End User (2014-2019) (MT)
Table North America Human Growth Hormone Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Human Growth Hormone Drugs Market Share by End User
Figure Europe Human Growth Hormone Drugs Sales Growth Rate 2014-2019 (MT)
Figure Europe Human Growth Hormone Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Human Growth Hormone Drugs Sales by Countries (2014-2019) (MT)
Table Europe Human Growth Hormone Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Human Growth Hormone Drugs Sales Market Share by Countries
Table Europe Human Growth Hormone Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Human Growth Hormone Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Human Growth Hormone Drugs Revenue Market Share by Countries
Figure Germany Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure Germany Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure France Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure UK Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure Italy Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure Russia Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Human Growth Hormone Drugs Sales by Product (2014-2019) (MT)
Table Europe Human Growth Hormone Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Human Growth Hormone Drugs Market Share by Product
Table Europe Human Growth Hormone Drugs Sales by End User (2014-2019) (MT)
Table Europe Human Growth Hormone Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Human Growth Hormone Drugs Market Share by End User
Figure Asia Pacific Human Growth Hormone Drugs Sales Growth Rate 2014-2019 (MT)
Figure Asia Pacific Human Growth Hormone Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Human Growth Hormone Drugs Sales by Countries (2014-2019) (MT)
Table Asia Pacific Human Growth Hormone Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Human Growth Hormone Drugs Sales Market Share by Countries
Table Asia Pacific Human Growth Hormone Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Human Growth Hormone Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Human Growth Hormone Drugs Revenue Market Share by Countries
Figure China Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure China Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure Japan Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure Korea Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure India Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure Australia Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure Indonesia Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure Malaysia Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure Philippines Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure Thailand Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure Vietnam Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure Singapore Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Human Growth Hormone Drugs Sales by Product (2014-2019) (MT)
Table Asia Pacific Human Growth Hormone Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Human Growth Hormone Drugs Market Share by Product
Table Asia Pacific Human Growth Hormone Drugs Sales by End User (2014-2019) (MT)
Table Asia Pacific Human Growth Hormone Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Human Growth Hormone Drugs Market Share by End User
Figure Central & South America Human Growth Hormone Drugs Sales Growth Rate 2014-2019 (MT)
Figure Central & South America Human Growth Hormone Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Human Growth Hormone Drugs Sales by Countries (2014-2019) (MT)
Table Central & South America Human Growth Hormone Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Human Growth Hormone Drugs Sales Market Share by Countries
Table Central & South America Human Growth Hormone Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Human Growth Hormone Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Human Growth Hormone Drugs Revenue Market Share by Countries
Figure Brazil Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure Brazil Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure Argentina Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Human Growth Hormone Drugs Sales by Product (2014-2019) (MT)
Table Central & South America Human Growth Hormone Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Human Growth Hormone Drugs Market Share by Product
Table Central & South America Human Growth Hormone Drugs Sales by End User (2014-2019) (MT)
Table Central & South America Human Growth Hormone Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Human Growth Hormone Drugs Market Share by End User
Figure Middle East and Africa Human Growth Hormone Drugs Sales Growth Rate 2014-2019 (MT)
Figure Middle East and Africa Human Growth Hormone Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Human Growth Hormone Drugs Sales by Countries (2014-2019) (MT)
Table Middle East and Africa Human Growth Hormone Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Human Growth Hormone Drugs Sales Market Share by Countries
Table Middle East and Africa Human Growth Hormone Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Human Growth Hormone Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Human Growth Hormone Drugs Revenue Market Share by Countries
Figure GCC Countries Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure GCC Countries Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure Turkey Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure Egypt Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Human Growth Hormone Drugs Sales Growth Rate (2014-2019) (MT)
Figure South Africa Human Growth Hormone Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Human Growth Hormone Drugs Sales by Product (2014-2019) (MT)
Table Middle East and Africa Human Growth Hormone Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Human Growth Hormone Drugs Market Share by Product
Table Middle East and Africa Human Growth Hormone Drugs Sales by End User (2014-2019) (MT)
Table Middle East and Africa Human Growth Hormone Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Human Growth Hormone Drugs Market Share by End User
Table Eli Lilly and Company (US) Company Details
Table Eli Lilly and Company (US) Human Growth Hormone Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Eli Lilly and Company (US) Recent Development
Table Ferring Holding SA (Switzerland) Company Details
Table Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Ferring Holding SA (Switzerland) Recent Development
Table Genentech, Inc. (US) Company Details
Table Genentech, Inc. (US) Human Growth Hormone Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Genentech, Inc. (US) Recent Development
Table GeneScience Pharmaceuticals Co., Ltd. (China) Company Details
Table GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table GeneScience Pharmaceuticals Co., Ltd. (China) Recent Development
Table Merck KgaA (Germany) Company Details
Table Merck KgaA (Germany) Human Growth Hormone Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Merck KgaA (Germany) Recent Development
Table Novo Nordisk A/S (Denmark) Company Details
Table Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Novo Nordisk A/S (Denmark) Recent Development
Table Pfizer, Inc. (US) Company Details
Table Pfizer, Inc. (US) Human Growth Hormone Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Pfizer, Inc. (US) Recent Development
Table Sandoz International GmbH (Germany) Company Details
Table Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Sandoz International GmbH (Germany) Recent Development
Table Global Human Growth Hormone Drugs Sales Forecast by Regions 2019-2025 (MT)
Table Global Human Growth Hormone Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Human Growth Hormone Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Human Growth Hormone Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Human Growth Hormone Drugs Sales Forecast by Product 2019-2025 (MT)
Table Global Human Growth Hormone Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Human Growth Hormone Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Human Growth Hormone Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Human Growth Hormone Drugs Sales Forecast by End User 2019-2025 (MT)
Table Global Human Growth Hormone Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Human Growth Hormone Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure North America Human Growth Hormone Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Human Growth Hormone Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Europe Human Growth Hormone Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Human Growth Hormone Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Asia Pacific Human Growth Hormone Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Human Growth Hormone Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Central & South America Human Growth Hormone Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Human Growth Hormone Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Middle East and Africa Human Growth Hormone Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Human Growth Hormone Drugs Value Chain
Table Human Growth Hormone Drugs Customers List
Table Human Growth Hormone Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs